Exact Mass: 501.16329840000003
Exact Mass Matches: 501.16329840000003
Found 71 metabolites which its exact mass value is equals to given mass value 501.16329840000003
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cabozantinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor
pseudostylopine-8beta-D-glucopyranoside
C25H27NO10 (501.1634882000001)
2-[[(E)-3-[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoyl]amino]pentanedioic acid
C25H27NO10 (501.1634882000001)
Cys Asp His Gln
Cys Asp Gln His
Cys Glu His Asn
Cys Glu Asn His
Cys His Asp Gln
Cys His Glu Asn
Cys His Asn Glu
Cys His Gln Asp
Cys Asn Glu His
Cys Asn His Glu
Cys Gln Asp His
Cys Gln His Asp
Asp Cys His Gln
Asp Cys Gln His
Asp His Cys Gln
Asp His Gln Cys
Asp Gln Cys His
Asp Gln His Cys
Glu Cys His Asn
Glu Cys Asn His
Glu His Cys Asn
Glu His Asn Cys
Glu Asn Cys His
Glu Asn His Cys
His Cys Asp Gln
His Cys Glu Asn
His Cys Asn Glu
His Cys Gln Asp
His Asp Cys Gln
His Asp Gln Cys
His Glu Cys Asn
His Glu Asn Cys
His Asn Cys Glu
His Asn Glu Cys
His Gln Cys Asp
His Gln Asp Cys
Asn Cys Glu His
Asn Cys His Glu
Asn Glu Cys His
Asn Glu His Cys
Asn His Cys Glu
Asn His Glu Cys
Gln Cys Asp His
Gln Cys His Asp
Gln Asp Cys His
Gln Asp His Cys
Gln His Cys Asp
Gln His Asp Cys
Aluminium tris(4-methyl-8-quinolinolate)
C30H24AlN3O3 (501.16329840000003)
Anthra(1,9-cd)pyrazol-6(2H)-one, 7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-(methylamino)ethyl)amino)-, dihydrochloride, monohydrate
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
L-Gamma-Glutamyl-S-[(9s,10s)-10-Hydroxy-9,10-Dihydrophenanthren-9-Yl]-L-Cysteinylglycine
C24H27N3O7S (501.15696320000006)
(9R,10R)-9-(S-Glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene
C24H27N3O7S (501.15696320000006)
Cabozantinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor
N-[(3,5-difluorophenyl)methyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetamide
N-[(3,5-difluorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetamide
N-[(3,5-difluorophenyl)methyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetamide
N-[(3,5-difluorophenyl)methyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-2-oxanyl]acetamide
2-[[(E)-3-[2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoyl]amino]pentanedioic acid
C25H27NO10 (501.1634882000001)